Objective: Circulating leptin levels show a high degree of individual variability even after the main effect of body fatness is accounted for. We therefore wanted to determine the roles of variation in body composition, age, sex and polymorphisms of the UCP2 gene and promoter region on levels of circulating leptin. Subjects: One hundred and fifty Caucasian subjects, which represented a cross-section of the population from NE, Scotland, were recruited. Measurements: Body composition was measured using dual X-ray absorptiometry. Fasted circulating leptin, insulin, T3 and T4 levels were measured, and all individuals were genotyped for the UCP2 polymorphisms A55V, -866G4A and exon-8 ins/del. Results: The results indicate that circulating leptin was significantly related to sex and principle component (PC) scores representing overall adipose tissue mass and a second representing the contrast of central to peripheral bone mineral content. Residual leptin was associated with the A55V polymorphism (Po 0.001) explaining 11.3% of the residual variance. There was a marginal effect associated with exon-8 ins/del (P ¼ 0.045) explaining 4.4% of the residual variance in leptin. Log e transformed circulating fasting insulin was related to PC scores representing general adiposity and sex. Residual Log e insulin was associated with the A55V and exon-8 ins/del polymorphisms explaining 5.7% (P ¼ 0.015) and 5% (P ¼ 0.026) of the residual variation, respectively. The -866G4A polymorphism was not significantly associated with residual leptin or insulin. Leptin and insulin were significantly (P ¼ 0.007) correlated. Statistically removing the effect of insulin on leptin still showed association between leptin and A55V (P ¼ 0.002). Removing the effect of leptin on insulin, the A55V polymorphism was no longer significant (P ¼ 0.120). After accounting for the correlation between insulin and leptin, the exon-8 ins/del was no longer significant for residual leptin (P ¼ 0.119) or Log e insulin (P ¼ 0.252). Conclusion: These data suggest that the A55V polymorphism directly affected the levels of leptin but not via an effect on insulin.
Introduction
Leptin is a cytokine produced almost exclusively in white adipose tissue, first identified from positional cloning of a mutated gene responsible for the obese phenotype in the ob/ob mouse. 1 The phenotype of the ob/ob mouse, involving both hyperphagia 2 and reduced energy expenditure, 3 quickly identified leptin as a key hormone involved in regulation of energy balance. The fact that it is primarily produced in white adipose tissue led to speculation that leptin acts as an adipostatic signal 4, 5 regulating body fatness, although other suggestions were that it was a more immediate signal in relation to food intake. 6, 7 It is now clear that leptin varies diurnally in relation to feeding behaviour, 8, 9 but at the same time baseline levels, in fasted subjects, primarily reflect body fatness. 10, 11 Hence, it may play both roles.
The relationship between body fatness and circulating leptin is characterised by a large degree of variation. 10, 11 Some of this variance is linked to sex, 11 but the causes and consequences of the remaining variation remain uncertain. Production of leptin in vitro appears to vary in adipocytes from different adipose tissue depots. 12, 13 If these differences are replicated in vivo, variation in the total leptin signal may reflect the differential contribution made by different fat stores. Leptin gene expression and production is regulated by many physiological signals including insulin, 14, 15 the sympathetic system, 16 growth hormone, 14 polyunsaturated fatty acids, 17 steroids, 18 thyroid hormones, 12 retinoic acid 13 and leptin itself. 19 Variations in levels of these regulatory factors may contribute to the variation in basal circulating leptin levels. Genetic factors may also play a role. Heterozygous individuals carrying single mutations of the ob gene, in both rodents 20 and humans, 21 appear to produce lower levels of leptin at given levels of body fatness. The complexity of the regulation of leptin production means that many genetic polymorphisms may interact to produce the observed variations in circulating leptin levels. Heterozygous individuals for the leptin gene are suggested to be fatter than wild-type relatives because they compensate for their low tissue production rates of leptin. 21 Apart from effects on obesity, the consequences of the individual variability in leptin levels may be important, however, in many different respects, because leptin appears to play roles in several systems -influencing, for example, reproduction, 22, 23 bone metabolism, 24 as well as direct links to insulin resistance and diabetes, 25 hypertension and cardiovascular disease.
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UCP2 is a mitochondrial uncoupling protein that has widespread tissue distribution including expression in both white and brown adipocytes that may be associated with variation in leptin production. There are several common polymorphisms of UCP2 27 in European populations. The nonsynonymous single-nucleotide polymorphism (SNP) in exon-4 (C-to-T substitution at position 164) results in changing an alanine to valine at codon 55 (Ala55Val or A55V) and has been linked to variations in energy balance via effects on resting metabolic rate and nocturnal physical activity, 28, 29 and type 2 diabetes. 30 The common À866
promoter (-866G4A) polymorphism has been shown to be associated with a range of obesity-related phenotypes. The À866 A allele has been associated with reduced risk of obesity, 31 reduced insulin sensitivity and increased risk of type 2 diabetes, [32] [33] [34] [35] and an increased risk of hypertension. 36 Although effects on obesity was not confirmed in additional studies, 37,38 the 45 bp ins/del in the 3 0 -untranscribed region of exon-8 showed associations with body mass index (BMI) and metabolic rate, 39 although associations with BMI were not supported by additional studies. 40 Cassell et al. 41 showed the exon-8 ins/del to be associated with fasting serum leptin concentration in obese women. Because there is evidence that insulin levels regulate leptin 42 a link between polymorphisms of UCP2 and leptin may arise because of effects associated with these polymorphisms on circulating insulin levels. Alternatively, there is also evidence that leptin may regulate insulin secretion. 25, 43 So associations between the UCP polymorphisms and insulin may arise via an effect on leptin.
In the present study, the effects of body composition, sex and age on the levels of circulating leptin in a cross-sectional sample of 150 Caucasian adults living in NE Scotland, UK, were explored. In addition, the impact of genetic polymorphisms of the UCP2 gene and its promoter region were investigated.
Materials and methods

Subject characteristics
One hundred and fifty adults (women n ¼ 107, men n ¼ 43), aged between 21 and 64 years and BMI range of 16.7-49.3 kg/m 2 , were recruited by newspaper advertisement to participate in this study. Demographically, Aberdeen is almost completely Caucasian, with only minor Asian communities. All the recruited subjects were Caucasian reflecting the local demography rather than selection bias. Subjects were included if they were not on any special medical diet, had stable weight (weight change less than 2 kg in the previous 3 months), were otherwise normal, based on extensive medical examination, screening blood tests and electrocardiogram, and took no regular prescribed medication, vitamin or mineral supplements. The study was approved by the Joint Ethical Committee of Grampian Health Board and The University of Aberdeen. Written informed consent was obtained. For further population details, see Johnstone et al.
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Body composition Body composition was assessed by dual-energy X-ray absorptiometry scanning (DEXA; Norland XR-26, Mark II-highspeed pencil beam scanner, Norland corporation, WI, USA equipped with dynamic filtration, with version 2.5.2 of the Norland software). Measurements were conducted in the morning, while the subjects were still in a fasted condition. We performed a whole-body DEXA scan and analysis, which generates estimates of fat-free mass, fat mass and bone mineral content in each of five separate body regions -the head, trunk, abdomen, arms and legs. Weekly quality control check with a phantom, over a period of 7 months, indicated a coefficient of variation (CV) of 0.94 and 1.52% for bone mineral density and bone mineral content, respectively.
Blood sampling
Whole blood was sampled from a large antecubital vein, in the morning, before breakfast using an 18G butterfly needle (Sarstedt, Nuernbrecht, Germany), and using an adaptor to sample into a 10 ml lithium heparin tube. The sample was spun (30 000 r.p.m. at 41C for 10 min) in a chilled centrifuge to obtain plasma, which was stored at À801C for batch analysis.
Plasma leptin
Circulating leptin in plasma was measured using a radioimmune assay (RIA) kit supplied by BioVendor (Heidelberg, Leptin, 
Plasma insulin
Plasma insulin was measured using an enzyme-linked immunosorbent assay (ELISA) kit supplied by LINCO Research (St Charles, Missouri, USA). Using the two quality controls provided, four replicates of each of these controls resulted in average accuracy of 12.8%. Precision across the four readings was 1.9%. All samples were run in duplicate, and the mean precision across all samples averaged 7.1%.
Plasma thyroid hormones
Circulating levels of T3 and T4 were measured using a rapid test kit developed by Diagnostic Automation Inc. (Calabasas, California, USA). No quality control standards were available, so we could not assess accuracy of the measurements. All samples were run in duplicate, and the mean precision across all individuals was 2.46% for T3 and 3.6% for T4.
DNA extraction and UCP2 genotyping
Genomic DNA was extracted from 2 ml of whole blood using QIAamp DNA Blood Midi Kit (QIAGEN, Hilden, Germany).
Using genomic DNA, all individuals were genotyped using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay as previously described for the UCP2 polymorphisms A55V, 28 -866G4A 34 and exon-8
ins/del. 38 The PCR-RFLP products were run on 20 cm vertical running 6% polyacrylamide gels and visualised under ultraviolet (UV) light after 20 min staining with ethidium bromide. All gels were scored on two separate occasions and, if discrepancies existed, genotypes were repeated.
Statistics
The correlation analysis revealed significant correlations for each of the three tissue types (fat, lean and bone mineral content) across all the body regions. Including individual body regions as predictors of circulating leptin levels would, therefore, be difficult to interpret because the predictors would not be orthogonal. The body composition was, therefore, re-described using principal component analyses for each of the three tissue types. Where appropriate, body composition traits were Log e transformed to conform to a normal distribution. As there were five body regions (head, trunk, abdomen, arms and legs), we calculated the first three principal components (PCs) only for each tissue. Scores on the three PCs for each tissue, along with sex and age, were used as predictors of the dependent variables of circulating leptin, Log e transformed insulin, T3 and Log e T4 using stepwise multiple regression, based on a combination of forward inclusion and backward elimination. We set the alpha to enter at 0.05, and for removal at 0.15. The model was not constrained to retain any of the variables. Once the best-fit equations for the four dependent variables had been obtained, residual variation taking these effects into account were calculated. Associations between the residual variance of leptin, Log e insulin, T3 and Log e T4 and the UCP2 genotypes of the subjects were made using linear models. Linear models were also used to investigate if body composition (scores on the three PCs for each tissue) was associated with the UCP2 genotypes. Bonferoni adjustments of the criterion to account for multiple testing were applied where appropriate. All analyses were performed using MINITAB (version 14.1).
Results
Body composition
The regional fat masses were all significantly positively correlated (Table 1a) . Individuals who had high adiposity in one region tended to have high levels of adiposity across all the other regions. The highest correlation was between the trunk and abdominal regions (r ¼ 0.956), and the lowest correlation was between fat masses of the head and the legs (r ¼ 0.369). Not surprisingly, fat mass of the head was poorly related to all the other regions. A similar pattern of significant positive correlations across all regions was also evident for the bone mineral contents (Table 1b) , with highest correlation between trunk and abdomen (r ¼ 0.911) and lowest, between head and legs (r ¼ 0.357). The pattern for lean tissue (Table 1c ) deviated slightly as all the regions were significantly positively correlated with each other: the Leptin, insulin and UCP2 A55V polymorphism KA Rance et al trunk and legs had the highest correlation, head and arms, the poorest (r ¼ 0.471). For lean tissue, the head was not as disparate as for fat tissue and bone mineral content. The variation in the three tissue types was described using principal components analyses, one for each tissue (Table 2) . For fat mass, the first principal component (FM-PC1) contained 77.5% of the original variation and was clearly a generalised adiposity component, as the loadings of all the variables were similar and in the same direction. FM-PC2 seemed to capture the contrast between the head and the rest of the body that had been revealed in the correlation matrix (Table 1a) , whereas FM-PC3 was dominated by the contrast between central (trunk and abdominal regions that had a negative effect on the scores: Figure 1a ) and peripheral region (legs and arm regions that had a positive effect: Figure 1b) . Together, these three components captured 97% of the original variation in fat mass. For bone mineral content, BMC-PC1 was also a generalised overall bone mineral size component (Table 2b) . BMC-PC2 captured the contrast between the head and the rest of the body, whereas BMC-PC3 seemed to reflect a central versus peripheral bone mineral distribution. The total variance retained in the first three components was 95%. For lean tissue mass (Table 2c) , LM-PC1 was also a generalised tissue size component, and LM-PC2 was dominated by the contrasts of the head to the rest of the body. LM-PC3 appeared to be a contrast between the abdominal lean mass and the masses of lean tissue in arms and legs. Together, these three PCs contained 96% of the original variation in lean mass.
Variation in circulating leptin levels -effects of body composition, sex and age The scores along the nine principal components (three for each tissue) were entered along with sex and age as predictors in a stepwise multiple regression, with circulating leptin levels as the dependent variable. Three factors entered as significant predictors: FM-PC1, BMC-PC3 and sex:
The most significant factors were the scores on FM-PC1, which was the generalized adiposity compartment, which explained 70.6% of the variation, and sex, which explained an additional 8% of the variation. These effects are illustrated in Figure 2 , which shows the positive effect of total fat mass on circulating leptin levels and the generally greater levels in women compared to men at any particular fat mass. Finally, the scores on BMC-PC3 (contrast between central and peripheral BMC) explained an additional 0.9% of the variability. BMC-PC3 was negatively associated with circulating leptin (Figure 3 ). Individuals with greater central BMC had on average slightly higher leptin levels, and those Leptin, insulin and UCP2 A55V polymorphism KA Rance et al with more peripheral BMC had on average slightly lower leptin levels. Together, the two body composition PCs and sex explained 79.6% of the total variation in circulating leptin levels.
Variation in circulating fasting insulin levels -effects of body composition, sex and age The scores along the nine principal components were entered along with sex and age as predictors in a stepwise multiple regression, with Log e circulating fasting insulin levels as the dependent variable. Two factors, FM-PC1 and sex, entered as significant predictors, resulting in the regression equation The significant factors were the scores on FM-PC1, the generalized adiposity compartment, which explained 27.3% of the variation, and sex, which explained an additional 6.2% of the variation. These effects are illustrated in Figure 4 , which shows the positive effect of total fat mass on circulating insulin levels and the generally greater levels in men compared to women at any particular fat mass. Together FM-PC1 and sex explained 33.5% of the total variation in circulating insulin levels.
Inter-relationship of leptin and insulin
Once the effects of body composition and sex had been accounted for, there was a significant positive association between levels of circulating insulin and levels of circulating leptin (F ¼ 7.4, P ¼ 0.007), but the effect was not strong (r 2 ¼ 0.05).
Thyroid hormones
We included scores along the nine body composition principle components, sex and age in a stepwise multiple regression with T3 and Log e T4 as the dependent variables. For T3, LM-PC1, LM-PC3 and BMC-PC1 entered the equation as significant predictors, explaining a total of 8.7% of variation:
The stepwise regression analysis for Log e T4 showed LM-PC1 and FM-PC3 to be significant predictors:
Log e T4 ¼ 2:39 þ 0:0260 LM À PCI À 0:0989 FM À PC3 ð4Þ
but they explained only 6.3% of total variation. Sex and age were not significant predictors of either T3 or Log e T4. The residual level of circulating leptin, once the effects of body composition, sex and age had been removed, was unrelated to the residual circulating levels of either T3 (F ¼ 0.02, P ¼ 0.89) or Log e T4 (F ¼ 1.50, P ¼ 0.223). Similarly, the levels of circulating insulin, once the effects of body composition 11.5 Figure 4 The relationship between Log e total fat mass and Log e circulating insulin levels in men K and women J.
Leptin, insulin and UCP2 A55V polymorphism KA Rance et al and sex were accounted for, were also unrelated to residual levels of T3 (F ¼ 1.47, P ¼ 0.227). However, there was a significant association between residual insulin and residual Log e T4 (F ¼ 4.45, P ¼ 0.037), although the relationship was not strong (r 2 ¼ 0.031).
Effects associated with the UCP2 polymorphisms Genotype data were available on all subjects from the cohort. The number of subjects carrying the different allelic types for the A55V polymorphism were A/A n ¼ 50, A/V n ¼ 75 and V/V n ¼ 25. At the promoter polymorphism -866G4A, the genotype frequencies were G/G n ¼ 50, G/A n ¼ 74 and A/A n ¼ 26. The allelic frequency at the UCP2 polymorphisms A55V and -866G4A was 0.42. For 78% of individuals, alleles were in linkage where genotypes were the same for the two polymorphisms. For the exon-8 ins/del genotype, frequencies were: ins/ins, n ¼ 74; ins/del, n ¼ 62 and del/del, n ¼ 14; giving an allele frequency of 0.30. Linear models were used to explore the polymorphismassociated effects of the three UCP2 polymorphisms on residual variation in circulating leptin level (corrected for FM-PC1, BMC-PC3 and sex). There was a highly significant association (F ¼ 8.89, Po 0.001) between residual circulating leptin levels and the A55V polymorphism, accounting for 11.3% of the residual variation (approximately 2% of the total variation). The genotype-associated effect was such that the AA and AV individuals were not significantly different from each other and not significantly different from zero with a mean effect of 0.143 residual standard deviation (s.d.) units. Levels for VV genotypes were significantly lower than zero with an effect of À0.780 residual s.d. units, the exon-8 ins/del was marginally significantly associated with residual circulating leptin (F ¼ 3.18, P o 0.045) accounting for 4.4% of residual variation. The -866G4A polymorphism was not significantly associated with circulating leptin levels (P40.05).
Residual insulin levels were calculated once the effects of FM-PC1 and sex had been removed, and linear models were used to determine if there was any association with the UCP2 polymorphisms. Like residual leptin, there was a significant association (F ¼ 4.31, P ¼ 0.015) between residual circulating insulin levels and the A55V polymorphism, accounting for 5.7% of the residual variation (approximately 4% of the total variation). The AA and AV genotypes were not significantly different from each other or different from zero, with a mean effect of 0.231 residual s.d. units. The VV genotype was associated with a significant reduction in insulin of À0.433 residual s.d. units. The exon-8 ins/del was significantly (F ¼ 3.76, Po 0.026) associated with residual circulating insulin, accounting for 5% of residual variation. The del/del genotype was associated with a significant reduction in insulin of À0.654 residual s.d. units, whereas ins/ins and ins/del genotypes were not significantly different from each other or zero (mean affect of 0.109 residual s.d. units).
The -866G4A polymorphism was not significantly associated with insulin (P40.05).
Previous studies have indicated that insulin may regulate leptin, and that leptin may regulate insulin. For either scenario, the A55V polymorphism-associated effects detected might arise as a result of the indirect regulatory effect of the other hormone. To explore this hypothesis, the effect of insulin on leptin was removed, and data were re-analysed to examine whether the effect associated with the UCP2 polymorphisms on leptin were still significant. The converse, where the effect of leptin on insulin was removed, was also carried out before exploring if the UCP2 associated effects on insulin. When the effect of insulin on circulating leptin levels was removed, the impact of the UCP2 A55V polymorphism on leptin was reduced (from 11.3 to 8.9%), but it was still highly significant (F ¼ 6.81, P ¼ 0.002). In contrast, when we removed the effect of leptin on insulin, the significant effect associated with the A55V polymorphism on circulating insulin levels disappeared (F ¼ 2.15, P ¼ 0.120). The effects associated with the exon-8 ins/del polymorphism did not remain significant (F ¼ 2.16, P ¼ 0.119 for leptin and F ¼ 1.39, P ¼ 0.252 for insulin) and so with the -866G4A polymorphism (F ¼ 0.95, P ¼ 0.389 for leptin and F ¼ 1.26, P ¼ 0.286 for insulin).
Polymorphisms of UCP2 had no effect on residual levels of circulating thyroid hormones (A55V polymorphism on T3 (F ¼ 0.43, P ¼ 0.649) and Log e T4 (F ¼ 1.49, P ¼ 0.230); exon-8 polymorphism on T3 (F ¼ 0.08, P ¼ 0.925) and Log e T4 (F ¼ 2.01, P ¼ 0.138) and -866G4A polymorphisms on T3 (F ¼ 1.59, P ¼ 0.207) and Log e T4 (F ¼ 0.95, P ¼ 0.388)).
Relationship between UCP2 polymorphism and body composition Scores along all nine principal components were entered as dependent variables in linear models with the UCP2 genotypes as factors. For all UCP2 polymorphisms, none of the associations reached significance (P40.05) without adjusting for multiple testing. The A55V polymorphism appears to exert an effect on circulating leptin level that has no resultant consequences for adiposity.
Discussion
Supporting previous studies, 10, 11 we found that the two most significant factors influencing circulating leptin levels were general adiposity and sex, 11 together explaining 79% of the observed variation. This still left a substantial unexplained variance. Previous studies have indicated leptin production varies across different adipose tissue depots when adipocytes are cultured in vitro. 44 However, the variance in circulating leptin reported here could not be attributed to regional differences in adiposity, as there was no effect of the contrast between central and peripheral adiposities (reflected in FM-PC3). This indicates it is unlikely that the detrimental Leptin, insulin and UCP2 A55V polymorphism KA Rance et al impacts of central adiposity on risk for the metabolic syndrome 45 are mediated via leptin.
Leptin gene expression and production is regulated by many physiological signals. We found support for a correlation between leptin levels and insulin, 14,15 but we did not find any correlation between circulating leptin levels and levels of T3, and only a weak association with Log e T4, contrasting previous suggestions that thyroid hormones may regulate leptin production. 46 A novel finding of the current study was that 11.3% of the residual circulating leptin level was associated with the A55V polymorphism in the UCP2 gene. This polymorphism has been previously linked to variation in resting metabolism 28 and type 2 diabetes, 30 but not previously associated with circulating leptin levels. Because all three UCP2 polymorphisms are known to be in linkage disequilibrium, 39 the association between the A55V polymorphism and circulating leptin could come about via direct effects associated with the exon-8 ins/del or indirect effects of the -866G4A polymorphism on regulators of leptin. Previous studies have linked the exon-8 ins/del polymorphism to variation in leptin; 41 therefore, there may be an effect due to linkage disequilibrium. Equally, as previous studies have suggested that insulin may regulate leptin production, the association between A55V polymorphisms and circulating leptin might arise via linkage to -866G4A which has been linked to variation in insulin production. [33] [34] [35] These possibilities were eliminated. First, there were no residual affects associated with the exon-8 ins/del once the correlation between leptin and insulin was removed. In addition, no association between the -866G4A polymorphism and circulating leptin or insulin levels could be found. However, an association between the A55V polymorphism and circulating insulin levels was observed. Because the levels of circulating insulin were correlated with the levels of circulating leptin (once all the confounding body composition and sex factors had been taken into account), it was still possible that an effect associated with A55V UCP2 and leptin was mediated by its effect on insulin. This is possible because polymorphic variation in UCP2 has a direct effect on pancreatic beta cell production of insulin in vitro. 47 Alternatively, because leptin may regulate insulin 43 levels, a primary link between the A55V polymorphism and leptin may generate a secondary association between the A55V polymorphism and insulin. The latter interpretation is favoured because when the effect of insulin on leptin was removed, the association between the UCP2 A55V polymorphism and leptin levels was barely diminished but remained highly significant. Conversely, when the effect of leptin on insulin was removed, any trace of an association between insulin levels and A55V UCP2 disappeared. This suggests a link between the polymorphism and leptin levels that does not involve insulin. In contrast to this study, Maestrini et al. 48 found no association between polymorphisms of UCP2 at either SNPs to be associated with circulating leptin levels in another European population of Caucasians. This difference in results may be explained by the more extensive analysis undertaken in this study, as without correction for the effects of body composition and sex on leptin before analysis, the association between the A55V UCP2 polymorphism and leptin levels is not observed.
